ESC Schedule 2014: Difference between revisions
m (Protected "ESC Schedule 2014": Schedule ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
|||
(48 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
Here is the page we will use to coordinate the TV events at ESC 2014. Open time slots are indicated below in red. | Here is the page we will use to coordinate the TV events at ESC 2014. Open time slots are indicated below in red. | ||
Filming | Filming Location: Hotel Arts Barcelona, Marina 19-21, Barcelona 08005 Spain. | ||
---- | ---- | ||
Line 8: | Line 8: | ||
==Click on Date for Detailed Schedule== | ==Click on Date for Detailed Schedule== | ||
[[{{PAGENAME}}# | [[{{PAGENAME}}#Friday, August 29, 2014| Friday, August 29, 2014]] | ||
[[{{PAGENAME}}# | [[{{PAGENAME}}#Saturday, August 30, 2014| Saturday, August 30, 2014]] | ||
[[{{PAGENAME}}# | [[{{PAGENAME}}#Sunday, August 31, 2014| Sunday, August 31, 2014]] | ||
[[{{PAGENAME}}#Tuesday, | [[{{PAGENAME}}#Monday, September 1, 2014| Monday, September 1, 2014]] | ||
[[{{PAGENAME}}#Tuesday, September 2, 2014| Tuesday, September 2, 2014]] | |||
[[{{PAGENAME}}#Wednesday, September 3, 2014| Wednesday, September 3, 2014]] | |||
---- | ---- | ||
== | ==Friday, August 29, 2014== | ||
===12:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===12:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
=== | ===1:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
=== | ===1:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===2:00 PM=== | ===2:00 PM=== | ||
Line 31: | Line 40: | ||
===2:30 PM=== | ===2:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===3:00 PM=== | ===3:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===3:30 PM=== | ===3:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===4:00 PM=== | ===4:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
== | ===4:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
==Saturday, August 30, 2014== | |||
===8:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===8:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===9:30 AM=== | ===9:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 10: | ''10:00 AM - 10:30 AM'' | ||
'''* | *'''Interviewee:''' Dr. Barbara Casadei | ||
*'''Topic:''' Perioperative statin treatment in cardiac surgery for the prevention of atrial fibrillation and perioperative myocardial damage: the Statin Therapy In Cardiac Surgery (STICS) Trial | |||
*'''Embargo Lift:''' Tuesday, September 2, 2014 at 11:20 AM | |||
===10:30 AM=== | ===10:30 AM=== | ||
''10:30 AM - 11: | ''10:30 AM - 11:00 AM'' | ||
'''* | *'''Interviewee:''' Dr. Michelle O’Donoghue | ||
*'''Topic:''' The Stabilization Of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) trial: Primary Results | |||
*'''Embargo Lift:''' Sunday, August 31, 2014 at 4:30 PM | |||
===11:00 AM=== | ===11:00 AM=== | ||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Dan Atar | |||
*'''Topic:''' Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the MITOCARE study | |||
*'''Embargo Lift:''' Monday, September 1, 2014 at 5:42 PM | |||
===11:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
== Sunday, August 31, 2014== | |||
===8:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===8:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===9:00 AM=== | |||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Gilles Montalescot | |||
*'''Topic:''' In-ambulance versus in-cath lab administration of ticagrelor in STEMI patients transferred for primary PCI: the randomized, double-blind ATLANTIC study | |||
*'''Embargo Lift:''' Monday, September 1, 2014 at 4:48 PM | |||
AND | |||
*'''Topic:''' Wrap-Up in French | |||
===9:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===10:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===10:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===11:00 AM=== | |||
''11:00 AM - 11:30 AM'' | |||
*'''Interviewee:''' Dr. Atul Verma | |||
*'''Topic:''' Optimal method and outcomes of catheter ablation of persistent atrial fibrillation: Results of the Prospective, Randomized STAR AF 2 Trial | |||
*'''Embargo Lift:''' Monday, September 1, 2014 at 12:12 PM | |||
===11:30 AM=== | ===11:30 AM=== | ||
''11:30 AM - 12:00 PM'' | |||
*'''Interviewee:''' Dr. Milton Packer | |||
*'''Topic:''' Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) | |||
*'''Embargo Lift:''' Sunday, August 31, 2014 at 8:30 AM | |||
===12:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===1:00 PM=== | |||
''1:00 PM - 1:30 PM'' | |||
*'''Interviewee:''' Dr. Inder Anand | |||
*'''Topic:''' Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: The ANTHEM-HF Study | |||
*'''Embargo Lift:''' Monday, September 1, 2014 at 11:18 AM | |||
===1:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===2:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
==Monday, September 1, 2014== | |||
===8:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===8:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===9:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===9:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> | ||
===10:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===10:30 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===11:00 AM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===11:30 AM=== | |||
''11:30 AM - 12:00 PM'' | |||
*'''Interviewee:''' Dr. Renato Lopes | |||
*'''Topic:''' Wrap-Up in Portuguese | |||
===12:00 PM=== | ===12:00 PM=== | ||
''12:00 | ''12:00 AM - 12:30 PM'' | ||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' Wrap-Up in Hebrew | |||
===12:30 PM=== | ===12:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===1:00 PM=== | ===1:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===1:30 PM=== | ===1:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===2:00 PM=== | ===2:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM - 3:00 PM'' | ''2:30 PM - 3:00 PM'' | ||
*''' | *'''Interviewee:''' Dr. Sergio Leonardi and Dr. Leonardo De Luca | ||
*'''Topic:''' | *'''Topic:''' Wrap-Up in Italian | ||
===3:00 PM=== | ===3:00 PM=== | ||
Line 114: | Line 196: | ||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | ''3:30 PM - 4:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Hisao Ogawa | ||
*'''Topic:''' | *'''Topic:''' The differences of the effects on lipid-lowering actions and glucose metabolisms between rosuvastatin and atorvastatin in Japanese diabetic patients with hyperlipidemia. | ||
*'''Embargo Lift:''' Sunday, August 31, 2014 at 5:42 PM | |||
AND | |||
*'''Topic:'''Wrap-Up in Japanese | |||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:30 PM'' | ''4:00 PM - 4:30 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Philippe Meurin | ||
*'''Topic:''' | *'''Topic:''' Colchicine for Post- operative Pericardial Effusion: The post-operative pericardial effusion (POPE-2) Study. A multicenter, double-blind, randomized trial | ||
*'''Embargo Lift:''' Sunday, August 31, 2014 at 9:42 PM | |||
===4:30 PM=== | ===4:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
= | |||
== | ==Tuesday, September 2, 2014== | ||
===8:00 AM=== | ===8:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===8:30 AM=== | ===8:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===9:30 AM=== | ===9:30 AM=== | ||
''9:30 AM - 10:00 AM'' | |||
*'''Interviewee:''' Dr. Thomas Pilgrim | |||
*'''Topic:''' Randomized comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization | |||
*'''Embargo Lift:''' Monday, September 1, 2014 at 11:00 AM | |||
===10:00 AM=== | ===10:00 AM=== | ||
''10:00 AM - 10:30 AM'' | ''10:00 AM - 10:30 AM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Riccardo Cappato | ||
*'''Topic:''' | *'''Topic:''' The X-VERT Trial: A comparison of oral rivaroxaban once daily with dose-adjusted Vitamin K Antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion | ||
*'''Embargo Lift:''' | *'''Embargo Lift:''' Tuesday, September 2, 2014 at 11:18 AM | ||
===10:30 AM=== | ===10:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===11: | ===11:15 AM=== | ||
''11: | ''11:15 AM - 11:30 AM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Massimo Imazio | ||
*'''Topic:''' | *'''Topic:''' COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial). | ||
*'''Embargo Lift:''' | *'''Embargo Lift:''' Sunday, August 31, 2014 at 10:00 AM | ||
===11:30 AM=== | ===11:30 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
= | |||
===12:30 PM=== | ===12:30 PM=== | ||
''12:30 PM - 1:00 PM | ''12:30 PM - 1:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Anthony Gershlick | ||
*'''Topic:''' | *'''Topic:''' Complete versus Lesion only PRimary -PCI Trial (CvLPRIT): Treat the infarct related artery only or all lesions | ||
*'''Embargo Lift:''' Monday, | *'''Embargo Lift:''' Monday, September 1, 2014 at 4:30 PM | ||
===1:00 PM=== | ===1:00 PM=== | ||
''1:00 PM - 1:30 PM | ''1:00 PM - 1:30 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Paul Armstrong | ||
*'''Topic:''' | *'''Topic:''' Wrap-Up from a Canadian perspective | ||
===1:30 PM=== | ===1:30 PM=== | ||
''1:30 PM - 2:00 PM | ''1:30 PM - 2:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Bongani Mayosi | ||
*'''Topic:''' A | *'''Topic:''' IMPI Steroid Study: A Trial of Adjunctive Prednisolone in Tuberculous Pericarditis | ||
*'''Embargo Lift:''' | *'''Embargo Lift:''' Tuesday, September 2, 2014 at 12:12 PM | ||
===2:00 PM=== | ===2:00 PM=== | ||
''2:00 PM | ''2:00 PM - 2:30 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Freek W.A. Verheugt | ||
*'''Topic:''' | *'''Topic:''' ESC 2014 Wrap-Up in Dutch | ||
===2:30 PM=== | ===2:30 PM=== | ||
''2:30 PM | ''2:30 PM - 3:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Lorenz Räber | ||
*'''Topic:''' | *'''Topic:''' Effect of high-intensity statin therapy on atherosclerosis in patients with ST-elevation myocardial infarction: Results of the prospective, longitudinal intravascular ultrasound follow-up study | ||
*'''Embargo Lift:''' Tuesday, September 2, 2014 at 11:54 AM | |||
===3:00 PM=== | ===3:00 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===3:30 PM=== | ===3:30 PM=== | ||
''3:30 PM - 4:00 PM'' | ''3:30 PM - 4:00 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Stine Darkner and Dr. Jesper Swendsen | ||
*'''Topic:''' | *'''Topic:''' Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: A double-blind, randomized, placebo-controlled study | ||
*'''Embargo Lift:''' Tuesday, September 2, 2014 at 11:36 AM | |||
===4:00 PM=== | ===4:00 PM=== | ||
''4:00 PM - 4:30 PM'' | ''4:00 PM - 4:30 PM'' | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Philip Aylward | ||
*'''Topic:''' | *'''Topic:''' Wrap-Up from a Pacific Rim perspective | ||
===4:30 PM=== | ===4:30 PM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
== | ==Wednesday, September 3, 2014== | ||
===8:00 AM=== | ===8:00 AM=== | ||
Line 259: | Line 301: | ||
===9:00 AM=== | ===9:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===9:30 AM=== | ===9:30 AM=== | ||
Line 276: | Line 316: | ||
===11:30 AM=== | ===11:30 AM=== | ||
''11:30 AM - 12:00 PM'' | |||
*'''Interviewee:''' Pr. Dr. Sigmund Silber | |||
*'''Topic:''' Wrap-Up in German | |||
===12:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===1:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===1:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===2:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===2:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===3:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===3:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===4:00 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | |||
===4:30 PM=== | |||
<font color=red>OPEN TIME SLOT</font> | <font color=red>OPEN TIME SLOT</font> |
Latest revision as of 14:24, 27 August 2014
Here is the page we will use to coordinate the TV events at ESC 2014. Open time slots are indicated below in red.
Filming Location: Hotel Arts Barcelona, Marina 19-21, Barcelona 08005 Spain.
Click on Date for Detailed Schedule
Friday, August 29, 2014
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Saturday, August 30, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Barbara Casadei
- Topic: Perioperative statin treatment in cardiac surgery for the prevention of atrial fibrillation and perioperative myocardial damage: the Statin Therapy In Cardiac Surgery (STICS) Trial
- Embargo Lift: Tuesday, September 2, 2014 at 11:20 AM
10:30 AM
10:30 AM - 11:00 AM
- Interviewee: Dr. Michelle O’Donoghue
- Topic: The Stabilization Of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) trial: Primary Results
- Embargo Lift: Sunday, August 31, 2014 at 4:30 PM
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Dan Atar
- Topic: Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the MITOCARE study
- Embargo Lift: Monday, September 1, 2014 at 5:42 PM
11:30 AM
OPEN TIME SLOT
Sunday, August 31, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Gilles Montalescot
- Topic: In-ambulance versus in-cath lab administration of ticagrelor in STEMI patients transferred for primary PCI: the randomized, double-blind ATLANTIC study
- Embargo Lift: Monday, September 1, 2014 at 4:48 PM
AND
- Topic: Wrap-Up in French
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
11:00 AM - 11:30 AM
- Interviewee: Dr. Atul Verma
- Topic: Optimal method and outcomes of catheter ablation of persistent atrial fibrillation: Results of the Prospective, Randomized STAR AF 2 Trial
- Embargo Lift: Monday, September 1, 2014 at 12:12 PM
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Milton Packer
- Topic: Results of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
- Embargo Lift: Sunday, August 31, 2014 at 8:30 AM
12:30 PM
OPEN TIME SLOT
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Dr. Inder Anand
- Topic: Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: The ANTHEM-HF Study
- Embargo Lift: Monday, September 1, 2014 at 11:18 AM
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
Monday, September 1, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Dr. Renato Lopes
- Topic: Wrap-Up in Portuguese
12:00 PM
12:00 AM - 12:30 PM
- Interviewee: Dr. Basil Lewis
- Topic: Wrap-Up in Hebrew
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Sergio Leonardi and Dr. Leonardo De Luca
- Topic: Wrap-Up in Italian
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: The differences of the effects on lipid-lowering actions and glucose metabolisms between rosuvastatin and atorvastatin in Japanese diabetic patients with hyperlipidemia.
- Embargo Lift: Sunday, August 31, 2014 at 5:42 PM
AND
- Topic:Wrap-Up in Japanese
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Philippe Meurin
- Topic: Colchicine for Post- operative Pericardial Effusion: The post-operative pericardial effusion (POPE-2) Study. A multicenter, double-blind, randomized trial
- Embargo Lift: Sunday, August 31, 2014 at 9:42 PM
4:30 PM
OPEN TIME SLOT
Tuesday, September 2, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
9:30 AM - 10:00 AM
- Interviewee: Dr. Thomas Pilgrim
- Topic: Randomized comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary revascularization
- Embargo Lift: Monday, September 1, 2014 at 11:00 AM
10:00 AM
10:00 AM - 10:30 AM
- Interviewee: Dr. Riccardo Cappato
- Topic: The X-VERT Trial: A comparison of oral rivaroxaban once daily with dose-adjusted Vitamin K Antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion
- Embargo Lift: Tuesday, September 2, 2014 at 11:18 AM
10:30 AM
OPEN TIME SLOT
11:15 AM
11:15 AM - 11:30 AM
- Interviewee: Dr. Massimo Imazio
- Topic: COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial).
- Embargo Lift: Sunday, August 31, 2014 at 10:00 AM
11:30 AM
OPEN TIME SLOT
12:30 PM
12:30 PM - 1:00 PM
- Interviewee: Dr. Anthony Gershlick
- Topic: Complete versus Lesion only PRimary -PCI Trial (CvLPRIT): Treat the infarct related artery only or all lesions
- Embargo Lift: Monday, September 1, 2014 at 4:30 PM
1:00 PM
1:00 PM - 1:30 PM
- Interviewee: Dr. Paul Armstrong
- Topic: Wrap-Up from a Canadian perspective
1:30 PM
1:30 PM - 2:00 PM
- Interviewee: Dr. Bongani Mayosi
- Topic: IMPI Steroid Study: A Trial of Adjunctive Prednisolone in Tuberculous Pericarditis
- Embargo Lift: Tuesday, September 2, 2014 at 12:12 PM
2:00 PM
2:00 PM - 2:30 PM
- Interviewee: Dr. Freek W.A. Verheugt
- Topic: ESC 2014 Wrap-Up in Dutch
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. Lorenz Räber
- Topic: Effect of high-intensity statin therapy on atherosclerosis in patients with ST-elevation myocardial infarction: Results of the prospective, longitudinal intravascular ultrasound follow-up study
- Embargo Lift: Tuesday, September 2, 2014 at 11:54 AM
3:00 PM
OPEN TIME SLOT
3:30 PM
3:30 PM - 4:00 PM
- Interviewee: Dr. Stine Darkner and Dr. Jesper Swendsen
- Topic: Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: A double-blind, randomized, placebo-controlled study
- Embargo Lift: Tuesday, September 2, 2014 at 11:36 AM
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Philip Aylward
- Topic: Wrap-Up from a Pacific Rim perspective
4:30 PM
OPEN TIME SLOT
Wednesday, September 3, 2014
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
11:30 AM - 12:00 PM
- Interviewee: Pr. Dr. Sigmund Silber
- Topic: Wrap-Up in German
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT